HEALTHSEMAFOR
US to provide new experimental Ebola drug
The US will supply an experimental Ebola drug, MBP134, to DR Congo for clinical trials. The WHO will also test Remdesivir, a COVID-19 treatment, on Ebola patients, as scientists race to develop vaccines for the new Bundibugyo strain. Disagreements over pathogen sharing have delayed lab testing for treatments and vaccines.
Mentioned
Related Signal
Adjacent reporting
- WHO plans Ebola vaccine trials
- Ebola vaccine for Bundibugyo strain could take months before human trials
- UK scientists developing new Ebola vaccine that could be ready in months
- HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy
- UK scientists developing new Ebola vaccine that could be ready in months
- Exclusive: Race begins to trial Ebola drugs amid current outbreak